Back to Search
Start Over
Blood pressure variability and target organ damage regression in hypertension
- Source :
- The Journal of Clinical Hypertension
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- The study by Triantafyllidi et al. supports the view that regression of subclinical cardiac damage requires an effective 24‐hour blood pressure (BP) control along with a reduction in BP variability and suggests that the assessment of BPV and its modifications during the course of therapy may be an useful approach in predicting the beneficial effects of treatment on cardiac structure. However, some aspects and limitations of this study require caution in drawing firm conclusions. So, further investigation is needed to determine if reduction of BPV is actually associated with a regression in cardiac and extracardiac organ damage to identify which which classes of antihypertensive drugs are most effective in reducing BPV, and to elucidate whether those treatments provide additional clinical benefit, independent of the conventional BP targets.
- Subjects :
- Blood pressure control
medicine.medical_specialty
organ damage
Endocrinology, Diabetes and Metabolism
Blood Pressure
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Internal medicine
Blood Pressure Variability
Internal Medicine
medicine
Humans
Cardiac structure
030212 general & internal medicine
Beneficial effects
Antihypertensive Agents
Subclinical infection
business.industry
Heart
blood pressure control
Target organ damage
Regression
Organ damage
Blood pressure
Hypertension
Commentary
Cardiology
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 17517176 and 15246175
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- The Journal of Clinical Hypertension
- Accession number :
- edsair.doi.dedup.....dad2566a27093039fc6a0991971616cb